The alternative evaluation criteria in phase III tests do not always mean the increases in the bone, the quality of life

(Medage today) – Chicago – Late tests that showed superiority for an experimental intervention on an final substitution point have not necessarily led to improvements in global survival (OS) or quality of life (QOL), according to a meta -epidemiology …